RVL Pharmaceuticals

Public

—N/Ahttps://rvlpharma.com

Last Round

Private Placement

Aug 15, 2023

Total Funding Raised

$236.93M

Company Overview

RVL Pharmaceuticals is a specialty pharmaceutical company that develops and commercializes eyecare and medical aesthetics products, including its FDA-approved product UPNEEQ® for droopy eyelids.

AI Layer

Non-AI

Keywords

Upneeqnon-surgical eyelid liftdroopy eyelid treatmenteyelid lift dropsacquired blepharoptosisspecialty pharmamedical aestheticslow-lying eyelidscash-pay pharmaptosis treatmentprescription eye dropsD2C pharmaophthalmic solutioneyecareB2B2C pharma

RVL Pharmaceuticals Comps

Public and private peers based on sector, stage, and business model.

RVL Pharmaceuticals comps — public and private peers by sector, stage, and business model
Company	Status	Est. Valuation	Rev Multiple
OpenAI	Private	$86.0B	~40x
Cohere	Private	$5.0B	--
Competitor 1	Public	$XX.XB	XXx
Competitor 2	Public	$XX.XB	XXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

RVL Pharmaceuticals Funding Rounds

Historical fundraising activity

Data table
Round	Date	Amount Raised	Valuation	Investors	Sources
Private Placement	Aug 15, 2023
Private Placement	Aug 8, 2022
Debt	Aug 4, 2022
Follow-on Offering	Oct 12, 2021
Debt	Oct 7, 2021
Follow-on Offering	Jul 16, 2020

View all Funding Rounds

Key People

Founding team and executive leadership

Lori Deo

Chief Executive Officer

Executive Team

JD Schaub

EVP, COO

Executive Team

RVL Pharmaceuticals Investors

Notable investors and investment history

RVL Pharmaceuticals investors
Investor	Rounds
Jefferies	IPO
H.C. Wainwright & Co.	Follow-on Offering
Athyrium Capital Management	Private Placement, Debt
RBC Capital Markets	IPO
Wells Fargo Securities	IPO
Avista Capital Partners	Debt, IPO, Private Placement

View all Investors

RVL Pharmaceuticals Filings

SEC and related filings with document metadata.

Data table
Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

RVL Pharmaceuticals Filings

SEC and related filings with document metadata.

Firmographic Details

Headquarters—

Employee Range61

Year Founded2000

Last FundingAug 15, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.